128 related articles for article (PubMed ID: 10387385)
1. Is prior authorization of topical tretinoin for acne cost effective?
Feldman SR; Fleischer AB; Chen GJ
Am J Manag Care; 1999 Apr; 5(4):457-63. PubMed ID: 10387385
[TBL] [Abstract][Full Text] [Related]
2. Prescribing patterns for topical retinoids: analyses of 15 years of data from the national ambulatory medical care survey.
Balkrishnan R; Bhosle MJ; Camacho F; Fleischer AB; Feldman SR
J Dermatolog Treat; 2010 May; 21(3):193-200. PubMed ID: 19895328
[TBL] [Abstract][Full Text] [Related]
3. Prescribing patterns for topical retinoids within NAMCS data.
Balkrishnan R; Sansbury JC; Shenolikar RA; Fleischer AB; Feldman SR
J Drugs Dermatol; 2005; 4(2):172-9. PubMed ID: 15776774
[TBL] [Abstract][Full Text] [Related]
4. Prior authorization for topical psoriasis treatments: is it cost-beneficial for managed care?
Balkrishnan R; Bhosle MJ; Fleischer AB; Feldman SR
J Dermatolog Treat; 2010 May; 21(3):178-84. PubMed ID: 19821787
[TBL] [Abstract][Full Text] [Related]
5. Most topical tretinoin treatment is for acne vulgaris through the age of 44 years: an analysis of the National Ambulatory Medical Care Survey, 1990-1994.
McConnell RC; Fleischer AB; Williford PM; Feldman SR
J Am Acad Dermatol; 1998 Feb; 38(2 Pt 1):221-6. PubMed ID: 9486677
[TBL] [Abstract][Full Text] [Related]
6. Healthcare utilization and costs of patients with rosacea in an insured population.
Romanowicz M; Stephenson JJ; Del Rosso JQ; Lenhart G
J Drugs Dermatol; 2008 Jan; 7(1):41-9. PubMed ID: 18246697
[TBL] [Abstract][Full Text] [Related]
7. [Pharmacoeconomy in acne--evaluation of benefit and economics].
Radtke MA; Schäfer I; Augustin M
J Dtsch Dermatol Ges; 2010 Mar; 8 Suppl 1():S105-14. PubMed ID: 20482687
[TBL] [Abstract][Full Text] [Related]
8. Topical retinoids in inflammatory acne: a retrospective, investigator-blinded, vehicle-controlled, photographic assessment.
Leyden JJ; Shalita A; Thiboutot D; Washenik K; Webster G
Clin Ther; 2005 Feb; 27(2):216-24. PubMed ID: 15811485
[TBL] [Abstract][Full Text] [Related]
9. The effect of the Rx-to-OTC switch of loratadine and changes in prescription drug benefits on utilization and cost of therapy.
Sullivan PW; Nair KV; Patel BV
Am J Manag Care; 2005 Jun; 11(6):374-82. PubMed ID: 15974556
[TBL] [Abstract][Full Text] [Related]
10. Tazarotene 0.1 percent cream plus clindamycin 1 percent gel versus tretinoin 0.025 percent gel plus clindamycin 1 percent gel in the treatment of facial acne vulgaris.
Tanghetti E; Dhawan S; Torok H; Kircik L
Dermatol Online J; 2007 Jul; 13(3):1. PubMed ID: 18328195
[TBL] [Abstract][Full Text] [Related]
11. Tretinoin gel microspheres 0.04% versus 0.1% in adolescents and adults with mild to moderate acne vulgaris: a 12-week, multicenter, randomized, double-blind, parallel-group, phase IV trial.
Berger R; Rizer R; Barba A; Wilson D; Stewart D; Grossman R; Nighland M; Weiss J
Clin Ther; 2007 Jun; 29(6):1086-97. PubMed ID: 17692723
[TBL] [Abstract][Full Text] [Related]
12. Pharmaceutical insurance and the demand for prescription pharmaceuticals in Västerbotten, Sweden.
Rudholm N
Scand J Public Health; 2005; 33(1):50-6. PubMed ID: 15764241
[TBL] [Abstract][Full Text] [Related]
13. Medication choice and associated health care outcomes and costs for patients with acne and acne-related conditions in the United States.
Patel P; Lin HC; Feldman SR; Fleischer AB; Nahata MC; Balkrishnan R
J Drugs Dermatol; 2011 Jul; 10(7):766-71. PubMed ID: 21720659
[TBL] [Abstract][Full Text] [Related]
14. Topical vitamin-A-acid in acne.
Zachariae H
Acta Derm Venereol Suppl (Stockh); 1980; Suppl 89():65-70. PubMed ID: 6451128
[No Abstract] [Full Text] [Related]
15. Pyogenic granulomas following topical application of tretinoin.
Teknetzis A; Ioannides D; Vakali G; Lefaki I; Minas A
J Eur Acad Dermatol Venereol; 2004 May; 18(3):337-9. PubMed ID: 15096149
[TBL] [Abstract][Full Text] [Related]
16. Costs and utilization associated with pharmaceutical adherence in a diabetic population.
Hepke KL; Martus MT; Share DA
Am J Manag Care; 2004 Feb; 10(2 Pt 2):144-51. PubMed ID: 15005507
[TBL] [Abstract][Full Text] [Related]
17. Improved efficacy and tolerability of retinoic acid in acne vulgaris: a new topical formulation with cyclodextrin complex psi.
Anadolu RY; Sen T; Tarimci N; Birol A; Erdem C
J Eur Acad Dermatol Venereol; 2004 Jul; 18(4):416-21. PubMed ID: 15196153
[TBL] [Abstract][Full Text] [Related]
18. Medication and medical service utilization for acne 1995-1998.
Stern RS
J Am Acad Dermatol; 2000 Dec; 43(6):1042-8. PubMed ID: 11100021
[TBL] [Abstract][Full Text] [Related]
19. Assessing the effect of Taiwan's outpatient prescription drug copayment policy in the elderly.
Liu SZ; Romeis JC
Med Care; 2003 Dec; 41(12):1331-42. PubMed ID: 14668666
[TBL] [Abstract][Full Text] [Related]
20. Effects of tazarotene 0.1 % cream in the treatment of facial acne vulgaris: pooled results from two multicenter, double-blind, randomized, vehicle-controlled, parallel-group trials.
Shalita AR; Berson DS; Thiboutot DM; Leyden JJ; Parizadeh D; Sefton J; Walker PS; Gibson JR;
Clin Ther; 2004 Nov; 26(11):1865-73. PubMed ID: 15639698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
